Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhong-Zhe Lin

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 7, 2019
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patientsZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
The Oncologist|May 17, 2017
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line GefitinibZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
Cancers|October 23, 2021
Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving ImmunotherapyYing-Chun Shen, Ching-Ping Yeh, Yung-Ming Jeng, et al.
European Radiology|July 21, 2022
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
Journal of Hepatocellular Carcinoma|June 10, 2024
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular CarcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
The Oncologist|July 26, 2014
Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancerKuo-Hsing Chen, Yu-Yun Shao, Zhong-Zhe Lin, et al.
Clinical Lung Cancer|December 3, 2014
Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinomaBin-Chi Liao, Yu-Yun Shao, Ho-Min Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2010
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptorsChia-Chi Lin, Hsin-Hsin Hsu, Chia-Tung Sun, et al.
The Oncologist|August 5, 2015
The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in AsiaHung-Yang Kuo, Zhong-Zhe Lin, Raymond Kuo, et al.
British Journal of Cancer|October 8, 2021
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin gradeRobin Kate Kelley, Rebecca Miksad, Irfan Cicin, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|July 7, 2019
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patientsZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
The Oncologist|May 17, 2017
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line GefitinibZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
Cancers|October 23, 2021
Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving ImmunotherapyYing-Chun Shen, Ching-Ping Yeh, Yung-Ming Jeng, et al.
European Radiology|July 21, 2022
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
Journal of Hepatocellular Carcinoma|June 10, 2024
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular CarcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
The Oncologist|July 26, 2014
Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancerKuo-Hsing Chen, Yu-Yun Shao, Zhong-Zhe Lin, et al.
Clinical Lung Cancer|December 3, 2014
Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinomaBin-Chi Liao, Yu-Yun Shao, Ho-Min Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 16, 2010
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptorsChia-Chi Lin, Hsin-Hsin Hsu, Chia-Tung Sun, et al.
The Oncologist|August 5, 2015
The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in AsiaHung-Yang Kuo, Zhong-Zhe Lin, Raymond Kuo, et al.
British Journal of Cancer|October 8, 2021
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin gradeRobin Kate Kelley, Rebecca Miksad, Irfan Cicin, et al.
Pageof 7